| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 734.79B | 686.55B | 601.95B | 643.98B | 573.03B |
| Gross Profit | 363.96B | 343.30B | 315.17B | 297.33B | 299.95B |
| EBITDA | 129.55B | 118.81B | 109.97B | 84.94B | 89.44B |
| Net Income | 151.01B | 117.52B | 122.23B | 91.35B | 87.54B |
Balance Sheet | |||||
| Total Assets | 2.85T | 2.37T | 2.08T | 1.69T | 1.45T |
| Cash, Cash Equivalents and Short-Term Investments | 539.85B | 483.27B | 542.61B | 396.00B | 343.49B |
| Total Debt | 1.09T | 934.32B | 822.49B | 721.77B | 612.62B |
| Total Liabilities | 1.64T | 1.43T | 1.26T | 1.09T | 951.93B |
| Stockholders Equity | 1.19T | 914.77B | 790.48B | 571.01B | 468.68B |
Cash Flow | |||||
| Free Cash Flow | 37.67B | 63.28B | 111.92B | 36.46B | 33.04B |
| Operating Cash Flow | 57.07B | 84.84B | 130.20B | 54.80B | 51.03B |
| Investing Cash Flow | -103.79B | -176.44B | -106.53B | -81.88B | -105.87B |
| Financing Cash Flow | 104.38B | 65.90B | 67.14B | 71.74B | 59.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥6.88B | 5.62 | ― | 3.35% | 6.84% | 9.89% | |
80 Outperform | ¥68.15B | 9.74 | ― | 2.82% | 5.56% | 35.28% | |
76 Outperform | ¥38.10B | 7.69 | ― | 2.70% | 1.09% | 15.49% | |
67 Neutral | ¥288.96B | 15.68 | ― | 0.82% | 15.27% | 17.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥13.62B | 1.91 | ― | 3.88% | 12.00% | ― | |
57 Neutral | ¥1.61T | 11.37 | ― | 1.59% | 7.03% | 28.86% |